Revisions to the Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP Guide addressing the manufacturing of advanced therapy medicinal products (ATMPs) as well as biological medicinal substances ...

Dublin, May 07, 2026 (GLOBE NEWSWIRE)-- The "Pharmaceutical Development of ATMPs (Sept 28th - Sept 29th, 2026)" has been added to ResearchAndMarkets.com's offering. Professionals in the field of ...

CCRM Nordic, Sahlgrenska Academy, and Sahlgrenska University Hospital are forming a strategic partnership relating to advanced therapy medicinal products (ATMPs). The parties have recently signed a ...

The European Medicines Agency (EMA) has recently adopted a guideline outlining the quality, non-clinical, and clinical requirements to support a clinical trial application for investigational advanced ...

(MENAFN- GlobeNewsWire - Nasdaq) Collaboration establishes a transatlantic connection enabling U.S. companies to leverage CELLforCURE's manufacturing capabilities in Europe, while European companies ...

Finalizing GMP requirements and quality standards for the development, manufacture, and clinical testing of ATMPs in the EU is proving to be a complex task. A consultation period on GMP guidelines (1) ...

The global Advanced Therapy Medicinal Products (ATMPs) market size was USD 8 billion in 2022 and is expected to reach USD 24 billion in 2032 NEW YORK , NY, UNITED STATES, April 23, ...

A new continuous bioprocessing platform for advanced therapy medicinal products (ATMPs) could help manufacturers increase yields and improve productivity, allowing them to treat larger groups of ...

In laboratories around the globe, scientists are diligently researching the limitless potential of advanced therapeutic medicinal products (ATMPs). These groundbreaking therapies are changing the face ...

San Antonio, Texas, Oct. 07, 2025 (GLOBE NEWSWIRE) -- BBG Advanced Therapies, a subsidiary of BioBridge Global (San Antonio, Texas, USA), and CELLforCURE, part of SEQENS Group, (Les Ulis, France) are ...